Low-throughput model design of protein folding inhibitors

被引:6
作者
Broglia, R. A.
Tiana, G.
Sutto, L.
Provasi, D.
Perelli, V.
机构
[1] Univ Milan, Dept Phys, I-20133 Milan, Italy
[2] INFN, Sez Milano, I-20133 Milan, Italy
[3] Niels Bohr Inst, DK-2100 Copenhagen, Denmark
关键词
folding inhibitors; drug design; simplified model; Monte Carlo sampling;
D O I
10.1002/prot.21275
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The stabilization energy of proteins in their native conformation is not distributed uniformly among all the amino acids, but is concentrated in few (short) fragments, fragments which play a key role in the folding process and in the stability of the protein. Peptides displaying the same sequence as these key fragments can compete with the formation of the most important native contacts, destabilizing the protein and thus inhibiting its biological activity. We present an essentially automatic method to individuate such peptidic inhibitors based on a low-throughput screening of the fragments which build the target protein. The efficiency and generality of the method is tested on proteins Src-SH3, G, CI2, and HIV-1-PR with the help of a simplified computational model. In each of the cases studied, we find few peptides displaying strong inhibitory properties, properties which are quite robust with respect to point mutations. The possibility of implementing the method through low-throughput experimental screening of the target protein is discussed.
引用
收藏
页码:469 / 478
页数:10
相关论文
共 35 条
[1]  
BALDWIN RL, 1990, TIBS, V24, P26
[2]   A folding inhibitor of the HIV-1 protease [J].
Broglia, RA ;
Provasi, D ;
Vasile, F ;
Ottolina, G ;
Longhi, R ;
Tiana, G .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2006, 62 (04) :928-933
[3]   Design of HIV-1-PR inhibitors that do not create resistance: Blocking the folding of single monomers [J].
Broglia, RA ;
Tiana, G ;
Sutto, L ;
Provasi, D ;
Simona, F .
PROTEIN SCIENCE, 2005, 14 (10) :2668-2681
[4]   Simple models of protein folding and of non-conventional drug design [J].
Broglia, RA ;
Tiana, G ;
Provasi, D .
JOURNAL OF PHYSICS-CONDENSED MATTER, 2004, 16 (06) :R111-R144
[5]   Resistance proof, folding-inhibitor drugs [J].
Broglia, RA ;
Tiana, G ;
Berera, R .
JOURNAL OF CHEMICAL PHYSICS, 2003, 118 (10) :4754-4758
[6]   Hierarchy of events in the folding of model proteins [J].
Broglia, RA ;
Tiana, G .
JOURNAL OF CHEMICAL PHYSICS, 2001, 114 (16) :7267-7273
[7]   Molecular dynamics studies on HIV-1 protease drug resistance and folding pathways [J].
Cecconi, F ;
Micheletti, C ;
Carloni, P ;
Maritan, A .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 2001, 43 (04) :365-372
[8]   Topological and energetic factors: What determines the structural details of the transition state ensemble and "en-route" intermediates for protein folding? An investigation for small globular proteins [J].
Clementi, C ;
Nymeyer, H ;
Onuchic, JN .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 298 (05) :937-953
[9]   SOLUBLE-PROTEINS - SIZE, SHAPE AND FUNCTION [J].
GOODSELL, DS ;
OLSON, AJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1993, 18 (03) :65-68
[10]   From knowledge-based potentials to combinatorial lead design in silico [J].
Grzybowski, BA ;
Ishchenko, AV ;
Shimada, J ;
Shakhnovich, EI .
ACCOUNTS OF CHEMICAL RESEARCH, 2002, 35 (05) :261-269